Glaukos Profit Margin 2014-2022 | GKOS
Current and historical gross margin, operating margin and net profit margin for Glaukos (GKOS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Glaukos net profit margin as of September 30, 2022 is -31.45%.
|Glaukos Annual Profit Margins
|Glaukos Quarterly Profit Margins
||Medical Instruments Manufacturing
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.